prucalopride: package leaflet

Resolor contains the active substance prucalopride.
Resolor belongs to a group of gut motility enhancing medicines (gastrointestinal prokinetics). It acts on the muscle wall of the gut, helping to restore the normal functioning of the bowel. Resolor is used for the treatment of chronic constipation in adults in whom laxatives do not work well enough.
Not for use in children and adolescents younger than 18 years.

Do not take Resolor:
- if you are allergic to prucalopride or any of the other ingredients of this medicine (listed in section 6).
- if you are on renal dialysis,
- if you suffer from perforation or obstruction of the gut wall, severe inflammation of the intestinal tract, such as Crohn’s disease, ulcerative colitis or toxic megacolon/megarectum.
Warnings and precautions
Talk to your doctor before taking Resolor.
Take special care with Resolor and tell your doctor if you:
- suffer from severe kidney disease,
- suffer from severe liver disease,
- are currently under supervision by a doctor for a serious medical problem such as lung or heart disease, nervous system or mental health problems, cancer, AIDS or a hormonal disorder.
If you have very bad diarrhoea, the contraceptive pill may not work properly and the use of an extra method of contraception is recommended. See the instructions in the patient leaflet of the contraceptive pill you are taking.

Other medicines and Resolor
Tell your doctor if you are taking, or have recently taken, or might take any other medicines.
Resolor with food and drink
Resolor can be taken with or without food and drinks, at any time of the day.
Pregnancy and breast-feeding
Resolor is not recommended for use during pregnancy.
- Tell your doctor if you are pregnant or planning to become pregnant.
- Use a reliable method of contraception while you’re taking Resolor, to prevent pregnancy.
- If you do become pregnant during treatment with Resolor, tell your doctor.
When breast-feeding, prucalopride can pass into breast milk. Breast-feeding is not recommended during treatment with Resolor. Talk to your doctor about this.
Ask your doctor for advice before taking any medicine.
Driving and using machines
Resolor is unlikely to affect your ability to drive or use machines. However, sometimes Resolor may cause dizziness and tiredness, especially on the first day of treatment, and this may have an effect on driving and use of machines.
Resolor contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Always take this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Take Resolor every day for as long as your doctor prescribes it.
The doctor may want to reassess your condition and the benefit of continued treatment after the first 4 weeks and thereafter at regular intervals.
The usual dose of Resolor for most patients is one 2 mg tablet once a day.
If you are older than 65 years or have severe liver disease, the starting dose is one 1 mg tablet once a day, which your doctor may increase to 2 mg once a day if needed.
Your doctor may also recommend a lower dose of one 1 mg tablet daily if you have severe kidney disease.
Taking a higher dose than recommended will not make the product work better.
Resolor is only for adults and should not be taken by children and adolescents up to 18 years.
If you take more Resolor than you should
It is important to keep to the dose as prescribed by your doctor. If you have taken more Resolor than you should, it is possible that you will get diarrhoea, headache and/or nausea. In case of diarrhoea, make sure that you drink enough water.
If you forget to take Resolor
Do not take a double dose to make up for a forgotten tablet. Just take your next dose at the usual time.

If you stop taking Resolor
If you stop taking Resolor, your constipation symptoms may come back again.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects mostly occur at the start of treatment and usually disappear within a few days with continued treatment.
The following side effects have been reported very commonly (may affect more than 1 in 10 people):
headache, feeling sick, diarrhoea and abdominal pain.
The following side effects have been reported commonly (may affect up to 1 in 10 people): decreased appetite, dizziness, vomiting, disturbed digestion (dyspepsia), windiness, abnormal bowel sounds, tiredness.
The following uncommon side effects have also been seen (may affect up to 1 in 100 people): tremors, pounding heart, rectal bleeding, increase in frequency of passing urine (pollakiuria), fever and feeling unwell. If pounding heart occurs, please tell your doctor.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.
Store in the original blister package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

What Resolor contains
The active substance is prucalopride.
One film-coated tablet of Resolor 1 mg contains 1 mg prucalopride (as succinate).
One film-coated tablet of Resolor 2 mg contains 2 mg prucalopride (as succinate).
The other ingredients are:
Lactose monohydrate (see section 2), microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, hypromellose, triacetin, titanium dioxide (E171), macrogol. The 2 mg tablet also contains iron oxide red (E172), iron oxide yellow (E172), indigo carmine aluminium lake (E132).

What Resolor looks like and contents of the pack
Resolor 1 mg film-coated tablets are white to off-white round shaped tablets marked “PRU 1” on one side.
Resolor 2 mg film-coated tablets are pink round shaped tablets marked “PRU 2” on one side.
Resolor is provided in aluminium/aluminium perforated unit dose blister (calendar marked) containing 7 tablets. Each pack contains 7x1, 14x1, 28x1 or 84x1 film-coated tablets.
Not all pack sizes may be marketed in your country.
Marketing Authorisation Holder
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
D02 HW68
Ireland
Manufacturer
Sanico NV
Veedijk 59
B-2300 Turnhout
Belgium
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
België/Belgique/Belgien
Takeda Belgium NV
Tél/Tel: +32 2 464 06 11 medinfoEMEA@takeda.com
Lietuva
Takeda, UAB
Tel: +370 521 09 070 medinfoEMEA@takeda.com
България
Такеда България ЕООД
Тел.: +359 2 958 27 36 medinfoEMEA@takeda.com
Luxembourg/Luxemburg
Takeda Belgium NV
Tél/Tel: +32 2 464 06 11 medinfoEMEA@takeda.com
Česká republika
Takeda Pharmaceuticals Czech Republic s.r.o.
Tel: +420 234 722 722 medinfoEMEA@takeda.com
Magyarország
Takeda Pharma Kft.
Tel.: +36 1 270 7030 medinfoEMEA@takeda.com
Danmark
Takeda Pharma A/S
Tlf: +45 46 77 10 10 medinfoEMEA@takeda.com
Malta
Drugsales Ltd
Tel: +356 21419070 safety@drugsalesltd.com
Deutschland
Takeda GmbH
Tel: +49 (0)800 825 3325 medinfoEMEA@takeda.com
Nederland
Takeda Nederland B.V.
Tel: +31 20 203 5492 medinfoEMEA@takeda.com
Eesti
Takeda Pharma AS
Tel: +372 6177 669 medinfoEMEA@takeda.com
Norge
Takeda AS
Tlf: +47 800 800 30 medinfoEMEA@takeda.com

Ελλάδα
Τakeda ΕΛΛΑΣ Α.Ε.
Tηλ: +30 210 6387800 medinfoEMEA@takeda.com
Österreich
Takeda Pharma Ges.m.b.H.
Tel: +43 (0) 800-20 80 50 medinfoEMEA@takeda.com
España
Takeda Farmacéutica España S.A.
Tel: +34 917 90 42 22 medinfoEMEA@takeda.com
Polska
Takeda Pharma Sp. z o.o.
Tel.: +48223062447 medinfoEMEA@takeda.com
France
Takeda France SAS
Tél: + 33 1 40 67 33 00 medinfoEMEA@takeda.com
Portugal
Takeda Farmacêuticos Portugal, Lda.
Tel: + 351 21 120 1457 medinfoEMEA@takeda.com
Hrvatska
Takeda Pharmaceuticals Croatia d.o.o.
Tel: +385 1 377 88 96 medinfoEMEA@takeda.com
România
Takeda Pharmaceuticals SRL
Tel: +40 21 335 03 91 medinfoEMEA@takeda.com
Ireland
Takeda Products Ireland Ltd
Tel: 1800 937 970 medinfoEMEA@takeda.com
Slovenija
Takeda Pharmaceuticals farmacevtska družba d.o.o.
Tel: + 386 (0) 59 082 480 medinfoEMEA@takeda.com
Ísland
Vistor hf.
Sími: +354 535 7000 medinfoEMEA@takeda.com
Slovenská republika
Takeda Pharmaceuticals Slovakia s.r.o.
Tel: +421 (2) 20 602 600 medinfoEMEA@takeda.com
Italia
Takeda Italia S.p.A.
Tel: +39 06 502601 medinfoEMEA@takeda.com
Suomi/Finland
Takeda Oy
Puh/Tel: 0800 774 051 medinfoEMEA@takeda.com
Κύπρος
A.POTAMITIS MEDICARE LTD
Τηλ: +357 22583333 a.potamitismedicare@cytanet.com.cy
Sverige
Takeda Pharma AB
Tel: 020 795 079 medinfoEMEA@takeda.com
Latvija
Takeda Latvia SIA
Tel: +371 67840082 medinfoEMEA@takeda.com
United Kingdom (Northern Ireland)
Takeda UK Ltd
Tel: +44 (0) 2830 640 902 medinfoEMEA@takeda.com
This leaflet was last revised in .
Detailed information on this medicine is available on the European Medicines Agency web site:
http://www.ema.europa.eu/.